Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762300
Hybrid Transobturator Tape Versus Conventional Synthetic Tape for Stress Urinary IncontinenceBenha UniversityRecruitingNot Applicable
NCT07762300Recruiting
Not Applicable
Hybrid Transobturator Tape Versus Conventional Synthetic Tape for Stress Urinary...Benha University
NCT07763431
Home-Use Dual-Light Antibacterial Photodynamic Therapy for Peri-Implant Mucositis in Full-Arch Implant ProsthesesUniversity of Medicine and Pharmacy at Ho Chi Minh CityNot Yet RecruitingNot Applicable
NCT07763431Not Yet Recruiting
Not Applicable
Home-Use Dual-Light Antibacterial Photodynamic Therapy for Peri-Implant Mucositi...University of Medicine an...
NCT07763613
Clinical Evaluation of the Pelvic Floor Fatigue Index (PFFI)Trabzon Kanuni Education and Research HospitalNot Yet Recruiting
NCT07763613Not Yet Recruiting
—
Clinical Evaluation of the Pelvic Floor Fatigue Index (PFFI)Trabzon Kanuni Education...
NCT07763106
Effectiveness and Costs of Pressure Ulcer Treatment and the Quality of Life of Patients With Pressure Ulcers Receiving Home-Based and Institutional CareSalus Care Center, Rybnik, PolandNot Yet RecruitingNot Applicable
NCT07763106Not Yet Recruiting
Not Applicable
Effectiveness and Costs of Pressure Ulcer Treatment and the Quality of Life of P...Salus Care Center, Rybnik...
NCT07762261
Impact of Generative AI on University Students' Learning Processes and Critical ThinkingAtaturk UniversityNot Yet RecruitingNot Applicable
NCT07762261Not Yet Recruiting
Not Applicable
Impact of Generative AI on University Students' Learning Processes and Critical...Ataturk University
NCT07764120
Quality of Life of Patients After Rectal Cancer Resection .University Hospital, GrenobleNot Yet Recruiting
NCT07764120Not Yet Recruiting
—
Quality of Life of Patients After Rectal Cancer Resection .University Hospital, Gren...
NCT07763951
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study.ADIUMCompletedNot Applicable
NCT07763951Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07763756
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer SurgeryAntalya City HospitalNot Yet RecruitingNot Applicable
NCT07763756Not Yet Recruiting
Not Applicable
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer Surg...Antalya City Hospital
NCT07763262
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha UniversityCompletedNot Applicable
NCT07763262Completed
Not Applicable
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha University
NCT07762989
Donor Ankle Sensorimotor Recovery After ACL Reconstruction With a Peroneus Longus Tendon AutograftGazi UniversityNot Yet Recruiting
NCT07762989Not Yet Recruiting
—
Donor Ankle Sensorimotor Recovery After ACL Reconstruction With a Peroneus Longu...Gazi University
NCT07762625
Couple-Coordinated Lifestyle Intervention for Women With a History of Gestational Diabetes MellitusCentral South UniversityNot Yet RecruitingNot Applicable
NCT07762625Not Yet Recruiting
Not Applicable
Couple-Coordinated Lifestyle Intervention for Women With a History of Gestationa...Central South University
NCT07763483
Do Endocrine Disruptors Accumulate in Children Undergoing Paediatric Dialysis?Hospices Civils de LyonNot Yet Recruiting
NCT07763483Not Yet Recruiting
—
Do Endocrine Disruptors Accumulate in Children Undergoing Paediatric Dialysis?Hospices Civils de Lyon
NCT07762274
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke and Brain Injury, Further Validation of RehAtt® DiSTRO Assessment of Cognitive and Visual FunctionDepartment of clinical sciences at Danderyd hospitalCompleted
NCT07762274Completed
—
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke an...Department of clinical sc...
NCT07763054
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia PatientsHaikou Affiliated Hospital of Central South University Xiangya School of MedicineRecruiting
NCT07763054Recruiting
—
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutro...Haikou Affiliated Hospita...
NCT07763418
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal FunctionBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07763418Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participan...Bristol-Myers Squibb
NCT07763405
Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic StrokeThe First Affiliated Hospital of Nanchang UniversityNot Yet RecruitingPhase 4
NCT07763405Not Yet Recruiting
Phase 4
Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic StrokeThe First Affiliated Hosp...
NCT07764328
This Study Aims to Evaluate Whether Milamend's Product Could Improve Hormone Balance in Women Who Suffer From Self-reported PCOS Symptoms.Mila Mend Inc.RecruitingNot Applicable
NCT07764328Recruiting
Not Applicable
This Study Aims to Evaluate Whether Milamend's Product Could Improve Hormone Bal...Mila Mend Inc.
NCT07762729
Gut Microbiota and Metabolic Development in Early Childhood: A 3-Year Follow-Up StudyChildren's Hospital of Fudan UniversityEnrolling By Invitation
NCT07762729Enrolling By Invitation
—
Gut Microbiota and Metabolic Development in Early Childhood: A 3-Year Follow-Up...Children's Hospital of Fu...
NCT07762833
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic DermatitisGalderma R&DNot Yet RecruitingPhase 3
NCT07762833Not Yet Recruiting
Phase 3
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Sub...Galderma R&D
Result Breakdown
Not yet recruiting12 (60%)
Completed4 (20%)
Recruiting3 (15%)
Enrolling by invitation1 (5%)
not_applicable10 (50%)
Not Specified7 (35%)
Phase 11 (5%)
Phase 41 (5%)
Phase 31 (5%)